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ABSTRACT
Budding yeast telomerase is mainly activated
by Tel1/Mec1 (yeast ATM/ATR) on Cdc13 from late
S to G2 phase of the cell cycle. Here, we demon-
strated that the telomerase-recruitment domain
of Cdc13 is also phosphorylated by Cdk1 at the
same cell cycle stage as the Tel1/Mec1-dependent
regulation. Phosphor-specific gel analysis demon-
strated that Cdk1 phosphorylates residues 308 and
336 of Cdc13. The residue T308 of Cdc13 is critical
for efficient Mec1-mediated S306 phosphorylation
in vitro. Phenotypic analysis in vivo revealed that
the mutations in the Cdc13S/TP motifs phosphory-
lated by Cdk1 caused cell cycle delay and telomere
shortening and these phenotypes could be partially
restored by the replacement with a negative charge
residue. In the absence of Ku or Tel1, Cdk1-
mediated phosphorylation of Cdc13 showed no
effect on telomere length maintenance. Moreover,
this Cdk1-mediated phosphorylation was required
to promote the regular turnover of Cdc13.
Together these results demonstrate that Cdk1
phosphorylates the telomerase recruitment domain
of Cdc13, thereby preserves optimal function
and expression level of Cdc13 for precise telomere
replication and cell cycle progression.
INTRODUCTION
Telomeres are dynamic DNA–protein complexes that pro-
tect the ends of linear chromosomes, prevent detrimental
chromosome rearrangements and defend against genomic
instability and the associated risk of cancer (1–3).
Telomeres, consisting of tandem repeats of short G-rich
sequences, are synthesized by the enzyme telomerase (4,5).
The catalytic core of telomerase is composed of a
reverse transcriptase and an RNA subunit. The reverse
transcriptase utilizes the RNA component as a template
to add the G-rich repeats onto the 30-ends of the chromo-
some (4–6). In most human somatic cells, telomerase
activity is absent, and telomeres are gradually shortened
with successive cell divisions due to incomplete replica-
tion, which eventually causes replicative senescence.
Once telomeres become suﬃciently short, they are thought
to lose the ability to protect the ends of the chromosomes
from being recognized as broken ends, and being sub-
jected to nuclease digestion and active recombinational
repair. Continuous telomere shortening in human ﬁbro-
blasts leads to chromosome fusions, crisis and apoptosis
(7). Very few human cells can bypass this crisis either
through telomerase reactivation or through an alternative
recombination pathway for telomere lengthening (8–10).
In budding yeast Saccharomyces cerevisiae, genes
encoding components of telomerase have been identiﬁed
and mutations in these genes cause a gradual loss of telo-
mere length (11,12). EST2 and TLC1 encode the reverse
transcriptase catalytic protein subunit and the templating
RNA, respectively (12–14). In addition, the protein
encoded by EST1 is associated with the RNA component
of telomerase (15–18). Other accessory factors, such as
Cdc13, are required for the in vivo action of telomerase.
Cdc13 is a single strand telomere-binding protein (19,20).
It forms a complex with Stn1 and Ten1. Cdc13, Stn1 and
Ten1 show homology to Rfa1, Rfa2 and Rfa3, respec-
tively. This replication protein A-like heterotrimeric com-
plex speciﬁcally binds single strand telomeric sequences
(21) and is required for both telomere protection and
telomerase recruitment (19,20,22). It recruits telomerase
to its site of action through an electrostatic interaction
between Cdc13 and Est1 (22,23).
DNA replication must take place only once per cell
cycle in eukaryotes. Cyclin-dependent kinases (CDKs),
particularly the budding yeast Cdk1 (Cdc28), have been
proven to phosphorylate and regulate a number of DNA
replication factors, including components of the origin
recognition complex, Orc1, Orc2 and Orc6, and MCM
proteins (24,25). Previous studies also demonstrated that
Present address:
Hung-Ji Tsai, Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA
*To whom correspondence should be addressed. Tel: +886 2 23123456 (ext. 88294); Fax: +886 2 23915293; E-mail: shuchunteng@ntu.edu.tw
 2009 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cdk1 regulates telomere replication (26–28). cdk1 cells
display defective telomere elongation and long single
G strand tails (26,28). Furthermore, very recently, Cdk1
has been reported to activate Cdc13 (29).In eukaryotes,
the maintenance of genome integrity relies on checkpoint
to properly detect and repair DNA damage caused
by environmental stresses or irregularities during DNA
metabolisms. Damage and replication defects are
recognized by the putative protein complex containing
protein kinases such as Tel1 and Mec1. We previously
reported that Cdc13 is a target of Tel1/Mec1-kinases
(30). This regulation occurs from late S to G2 phase of
the cell cycle and is required for telomerase recruitment
(31–33). In addition, we also observed a TEL1/MEC1-
independent phosphorylation of Cdc13 (30). We
wondered how these phosphorylations mediate Cdc13
functions at telomere replication and which kinase
contributes to the TEL1/MEC1-independent phosphor-
ylation. In this work, we show that Cdc13 is phosphor-
ylated in a cell cycle-dependent manner. Similar to the
Tel1/Mec1-dependent regulation, Cdk1-mediated phos-
phorylation of Cdc13 occurs at the same cell cycle stage.
We identiﬁed two phosphorylation sites. Inactivation of
both Cdk1 phosphorylation sites in Cdc13 results in telo-
mere shortening and delays the regular proteolysis of
Cdc13 and cell cycle progression. Thus, we suggest that
phosphorylation of Cdc13 by Cdk1 facilitates telomere
replication.
MATERIALS AND METHODS
Strains, plasmids, yeast and telomere experiments
All the yeast operations were performed by standard
methods (34). Yeast strains used in the study were deriva-
tives of YPH501 (MATa/MAT ura3-52/ura3-52 lys2-801
amber/lys2-801 amber ade2-101 ochre/ade2-101 ochre trp1
D63/trp D63 his3 D200/his3 D200 leu2- D1/leu2- D1). The
yeast strains carrying mec1 (all combined with sml1), tel1,
cdc13, hdf1 and CDC13-Myc9 were described previously
(15,35,36). cdc28-4 (37) and cdc28-as1 (38) strains were
kindly provided by Steven Reed and David Morgan,
respectively. pRS304cdc13-Myc9 was obtained from
Virginia Zakian (36,39) and pRS306cdc13 was constructed
by PCR containing the CDC13 open read frame and the
downstream 200nt. Point mutations were introduced into
CDC13 using QuikChange site-directed mutagenesis
(Stratagene). To generate chromosomal cdc13 mutants,
pRS306cdc13 mutants were XhoI-digested and trans-
formed into CDC13 strains, and the URA3 pop-out
mutants were selected from the 5-FOA-resistant colonies
using PCR analysis. pLD1(YIP, pGAL1-Sic1N) (40)
plasmid was kindly provided by John Diﬄey.
pKB174(CEN CDC28-HA TRP1) and pKB173(CEN
cdc28K40L-HA TRP1) (41) plasmids were generous gifts
from Orna Cohen-Fix. All primer sequences for PCR and
mutagenesis are available upon request. Telomere blot
analysis was performed as previously described (42,43).
Data shown are representatives of three or more experi-
ments from independent colonies.
Immunoprecipitation, gel electrophoresis, western blot
analysis and cell cycle analysis
To detect Cdc13, cells were grown in YPD broth. Whole
cell proteins were extracted by TCA precipitation (44)
and resolved by sodium dodecylsulfate–polyacrylamide
gel electrophoresis (SDS–PAGE) or SDS–PAGE contain-
ing 10mM of acrylamide-pendant Phos-tag
TM (Phos-tag
Consortium) (45) as previously described (46). Cdc13
was detected with a Myc antibody (Santa Cruz Biotech-
nology). A Rad53 antibody (gift of J. Diﬄey) was used to
detect Rad53. Images were captured and quantiﬁed by a
bioluminescence imaging system (UVP BioSpectrum AC
Imagine System, UVP). Cells were stained with propidium
iodide and the cell cycle analysis was performed by a ﬂow
cytometer (FACSCalibur 200, Becton Dickinson).
Inhibition of Cdk1 in cdc28-4 and cdc28-as1 strains
CDC13 in cdc28-4, W303 and cdc28-as1 strains was
chromosomally tagged with Myc9. cdc28-4 arrests cells
in G1, the stage that Cdc13 is usually under-phosphory-
lated, preventing us from distinguishing the lack of phos-
phorylation being directly due to the absence of Cdk1
from an indirect consequence of cell cycle arrest. To cir-
cumvent this problem, cdc28-4 cells were ﬁrst arrested
with nocodazole at 238C and shifted to 378C for 3h.
The cdc28-as1 cultures were split into halves for the
0.5mM 4-amino-1-tert-butyl-3-(10-naphthylmethyl) pyra-
zolo [3,4-d] pyrimidine (1-NMPP1) (47) and the mock
treatments.
Phosphatase treatment of immune complexes of Cdc13
Agarose-bound Cdc13 immunocomplexes were washed
twice with basic phosphatase (PPase) buﬀer (50mM
Tris–HCl, pH 7.9, 100mM NaCl, 1mM dithiothreitol,
10mM MgCl2). The beads were then incubated with
100U of calf intestinal PPase (New England Biolabs) for
30min at 308C. The reaction was stopped by addition of
ice-cold basic kinase buﬀer containing 10mM Na3VO4
and 10mM NaF.
Recombinant protein purification
pGEX-4TCDC13(1–252) was constructed by ligating the
PCR product containing amino acids 1–252 of Cdc13
from pRS314CDC13 into the NdeI- and EcoRI-treated
pGEX-4T (GE). pGEX-4TCDC13(252–491) was con-
structed by ligating the EcoRI- and ClaI/Klenow-treated
fragment, which contains amino acids 252–491 of Cdc13
from pRS314CDC13 into the EcoRI- and XhoI/Klenow-
treated pGEX-4T. pGEX-4TCDC13(601–781) was con-
structed by ligating the BglII- and SacI/Klenow-treated
fragment, which contains amino acids 601–781 of Cdc13
from pRS314CDC13 into the BamHI- and XhoI/Klenow-
treated pGEX-4T. pGEX-4TCDC13(276–332) was con-
structed as previously described (30). Recombinant
proteins were overexpressed in E. coli and puriﬁed as pre-
viously described (30). The bound GST-fusion proteins
were detected by Coomassie blue staining.
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Log phase cells were lyzed and immunoprecipitated by
incubation with an HA antibody and protein A beads.
The immunoprecipitation (IP)-kinase assay was per-
formed as described (48). Cdc28-HA or the kinase-dead
Cdc28
K40L-HA were puriﬁed from a protease-defected
strain, BJ2168, carrying plasmid pKB174 (CDC28-HA)
or pKB173 (cdc28
K40L-HA). KSC1333 (MEC1-HA
sml1::HIS3) (48) was kindly provided by Katsunori
Sugimoto.
De novo telomere addition assay
De novo telomere addition assay was performed as
previously described (49). UCC5706 strain was kindly
provided by Daniel Gottschling. CDC13, cdc13-T308A,
cdc13-T308D and cdc13-T308E were generated by one-
step chromosomal insertion using XhoI-digested
pRS304CDC13, pRS304cdc13-T308A, pRS304cdc13-
T308D and pRS304cdc13-T308E, respectively.
RESULTS
Cdk1-dependent Cdc13 phosphorylation in vivo
Under the examination of Tel1/Mec1-mediated phosphor-
ylation, we observed a TEL1/MEC1-independent phos-
phorylation of Cdc13 (Figure 1A). In order to elucidate
how these phosphorylations mediate other functions
of Cdc13 and to identify the kinase that contributes
to TEL1/MEC1-independent phosphorylation, we ﬁrst
investigated whether Cdc13 was phosphorylated in a cell
cycle-dependent manner. Western blot analysis showed
that Cdc13 is regulated in a cell cycle-dependent manner
(Figure 1B) and hyperphosphorylated from late S (40min
in Figure 1C) to G2 (60min in Figure 1C) stages. To
determine whether Cdk1 is involved in this cell cycle-
dependent phosphorylation, we examined Cdc13 phos-
phorylation in cdc28-4, SIC1 overexpressed and
cdc28-as1 strains. All three strains can be manipulated
to equip defective Cdk1 activity (37,38,40). The migration
of Cdc13 in gels was faster in these Cdk1-crippling back-
grounds (Figure 1D), suggesting that Cdc13 might be
phosphorylated in a CDK1-dependent manner in vivo.
The telomerase recruitment domain of Cdc13 is
phosphorylated by Cdk1 in vitro
One apparent hypothesis for the CDK1-dependent Cdc13
phosphorylation is that Cdc13 may be directly phosp-
horylated by Cdk1. The CDK family of kinases has a
preference for phosphorylation of serine in SP motifs or
threonine in TP motifs (25). A total of seven such motifs
were identiﬁed in Cdc13 (Figure 2A). Two of these sites in
Cdc13 were found in the telomerase recruitment domain
(T308 and S336) (Figure 2A). For the ﬁrst step in deter-
mining whether Cdc13 is a direct substrate of Cdk1, we
tested whether Cdk1 could phosphorylate Cdc13 in vitro.
Cdk1 immunoprecipitates were incubated under in vitro
kinase conditions in the presence of g-[
32P]-ATP and
recombinant GST-Cdc13(1–252), GST-Cdc13(252–491)
or GST-Cdc13(601–781) covering all seven Cdk1
consensus target sites. The reactions were subjected to
SDS–PAGE and autoradiography (Figure 2B). The phos-
phorylated GST-Cdc13(252–491) subunit was observed,
while neither GST alone nor other GST-Cdc13 proteins
showed detectable phosphorylation by Cdk1 (Figure 2B).
To conﬁrm that Cdk1 kinase activity was indeed necessary
for Cdc13 phosphorylation, assays were conducted using
extracts isolated from a mutant strain expressing an HA-
tagged Cdk1-kd protein with the amino acid lysine 40
mutated in its catalytic domain (41) (Figure 2B). Based
on assays using equivalent amounts of protein, inactiva-
tion of Cdk1 kinase activity completely eliminated Cdc13
phosphorylation. These results demonstrated that Cdk1
kinase phosphorylates Cdc13 directly.
There are three S/TP sites (residue 308, 336 and 460)
within the 225–491 fragment of Cdc13. To determine the
exact phosphorylation sites, we puriﬁed mutant GST-
Cdc13 containing single or double alanine (A) mutations
at these sites. These substrates were then used in the IP-
kinase assay. Compared to wild-type Cdc13, phosphory-
lation of the T308A Cdc13 subunit was drastically reduced
(Figure 2C). These results imply that T308 is the
major phosphorylation site of Cdc13. Double mutations
at T308S336A, but not at T308S460A, caused a further
reduction of phosphorylation, comparing to T308A alone
(Figure 2D). Therefore, our data suggested that the phos-
phorylation sites of Cdc13 by Cdk1 are located at amino
acids 308 and 336.
Since the Cdk1-mediated regulation on residue T308
is very close to a Mec1-mediated regulation on S306
of Cdc13 (30), we asked whether Cdk1 would modulate
the action of Mec1 on Cdc13, or vice versa. As shown in
Figure 2E, Cdk1 was able to phosphorylate Cdc13-S306A
and Mec1 was also able to phosphorylate Cdc13-T308A.
However, an attenuated Mec1-mediated phosphorylation
was observed in Cdc13-T308A. On the other hand,
the mutation on S306 made no major impact on the
Cdk1-mediated modiﬁcation on T308. These ﬁndings indi-
cated that the Cdk1-mediated phosphorylation might be
critical to promoting the action of Mec1 on Cdc13.
The telomerase recruitment domain of Cdc13 is
phosphorylated by Cdk1 in vivo
To verify whether residues 308 and 336 are indeed
Cdk1-mediated phosphorylation sites in vivo, we created
Cdc13 mutant strains at these sites. Compared to the
wild-type strain, the cdc13-T308A, cdc13-S336A and
cdc13-T308S336A mutants retained residual levels of
phosphorylated Cdc13 isoforms (Figure 3A), which
should be contributed from Tel1/Mec1-mediated phos-
phorylation. However, hyperphosphorylated forms of
Cdc13 in cdc13-T308A and cdc13-T308S336A cells were
reduced at the G2/M stage (Figure 3A), suggesting that
T308 is phosphorylated in vivo. Due to the high molecular
weight of Cdc13, the resolution of regular SDS–PAGE
was not high enough to discern multiple phosphorylated
forms of Cdc13. Therefore, a phosphor-speciﬁc gel using
acrylamide-pendant Phos-tag
TM (Phos-tag Consortium)
(45) was applied to augment the diﬀerence of phosphor-
ylation. Phosphorylation on T308 and S336 became more
3604 Nucleic Acids Research, 2009, Vol. 37,No. 11distinguishable in the Phos-tag gel (Figure 3B). Under the
help of Phos-tag, increases of migration were detected in
both T308A and S336A (Figure 3B). These data indicated
that both T308 and S336 are phosphorylated in vivo.
Since previous studies demonstrated that Tel1 makes
the major contribution to the activation of Cdc13 to
recruit telomerase (31–33), to understand if the phosphor-
ylation of T308 and S336 were Tel1-dependent, these
mutants were introduced into the tel1 cells. As shown in
Figure 3C, even in the absence of TEL1, reduction of the
phosphorylation level was further observed in T308A
mutation, comparing to the wild-type Cdc13. These ﬁnd-
ings argued that Cdk1-mediated phosphorylation does not
rely on the action of Tel1-mediated phosphorylation on
Cdc13.
We next examined whether T308 is authentically the
Cdk1-phosphorylated site in vivo, T308A mutation was
constructed in the cdc28-as1 strains. Compared to the
normal cdc28-as1 strain, T308A mutation did not further
convert the electrophoretic behavior of Cdc13 to a single
sharper band with greater mobility (Figure 3D). Similar
results were also observed in the Sic1-overexpressed strain
(Figure 3D). Therefore, we concluded that Cdc13 is phos-
phorylated by Cdk1 in vivo at T308.
Cdk1 phosphorylates Cdc13 at the late S and G2 phases
for proper cell cycle progression
Tel1 is highly enriched at short telomeres from S through
G2 phase (31–33). To determine whether Cdk1 targets
Cdc13 at a similar timing to the action of Tel1, the
status of Cdc13 phosphorylation was followed throughout
the cell cycle. As observed in Figure 4, Cdc13 hyperpho-
sphorylation was peaked at the late S and G2 phases,
which is identical to the timing of the action of Tel1 as
previously reported (31–33). This peak was diminished in
the cdc13-T308A strain, further indicating that Cdk1 plays
a critical role on the hyperphosphorylated peak from late
S to G2 phase observed in the wild-type cells (Figure 4A).
Following release from the arrest, a slight cell cycle delay
was observed in the cdc13-T308A strain (Figure 4B,
40min). In the absence of TEL1, a hyperphosphorylated
Cdc13 peak at the late S and G2 phases was still observed
(Figure 4A). This abnormal cell cycle progression was not
due to activation of the checkpoint (Figure 4C). These
results suggested that Cdk1-mediated phosphorylation
of Cdc13 shares the same cell cycle stage with the Tel1/
Mec1-mediated telomerase recruitment. However, this
phosphorylation is Tel1-independent and required for
accurate cell cycle progression.
Figure 1. Cdk1-dependent phosphorylation of Cdc13 in vivo.( A) MEC1/TEL1-independent phosphorylation of Cdc13. Cdc13 was chromosomally
tagged with Myc9. Lysates from wild-type and mec1 tel1 strains were immunoprecipitated by a Myc antibody and incubated in PPase buﬀer, PPase
buﬀer with PPase or PPase buﬀer containing PPase and PPase inhibitors (PI). Reactions were subjected to a 5.7% SDS–PAGE and transferred for
western blot analysis using a Myc antibody. Non-, hypo- and hyper-phosphorylated Cdc13 are marked with none, single and double asterisks,
respectively. (B) G2/M phase-speciﬁc phosphorylation of Cdc13. Lysates from a factor- or nocodazole-treated cells were extracted by TCA precip-
itation and Cdc13 phosphorylation was analyzed by western blot analysis. (C) Cell cycle-dependent phosphorylation of Cdc13. Overnight culture was
grown to early log phase in YEPD, and arrested in G1 with a factor. When over 90% of the cells, as determined by microscopy, exhibited cell cycle
arrest, cells were released into cell cycle. FACS analysis (showed at the right) of this sample indicated that cells had a 1N content of DNA. After
release from a factor, cells were collected at 20-min intervals for 180min and Cdc13 was analyzed by western blot analysis. (D) Cdk1-dependent
phosphorylation of Cdc13. Cdc13 phosphorylation was analyzed in cdc28-4, SIC1 overexpressed and cdc28-as1 strains, which all can be manipulated
to provide defective Cdk1 activities (37,38,40). cdc28-4 (a temperature sensitive mutant) was synchronized by nocodazole at 238C and shifted to 378C
for 3h; pGAL-Sic1 N transformants were treated with dextrose (D) or galactose (G) for 3h, and W303 (wild-type) and cdc28-as1 were treated with
or without 1-NMPP1 for 3h. Lysates were extracted and Cdc13 phosphorylation was analyzed by western blot analysis.
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To identify potential cellular functions of Cdk1-mediated
Cdc13 phosphorylation, we ﬁrst analyzed whether muta-
tions in these phosphorylation sites would aﬀect the
growth and replication of telomeres. In order to examine
the phenotypes, point mutations were introduced into
the untagged chromosomal copy of CDC13. As shown
in Figure 5, single mutation at residue T308 to A caused
telomere shortening. A slight growth defect was also
observed in T308A cells, which was further reﬂected in
its cell cycle proﬁle (Figure 4). These ﬁndings indicated
that phosphorylation on this residue is important for tel-
omere maintenance. Moreover, single mutation S336A or
double mutation T308S336A maintained similar telomere
lengths to those of wild-type and T308A, respectively
(Figure 5). These data indicated that the Cdk1-mediated
regulation on S336 does not contribute to the telomere
maintenance. While single mutation at residue 308 from
T to A caused telomere shortening and a cell cycle delay,
replacement of T308 with aspartic acid (D) or glutamic
acid (E) partially recovered these phenotypes (Figures 5
and S1, and data not shown). These results further con-
ﬁrmed that the negative charge on this residue is impor-
tant for telomere maintenance.
We next examined whether predisposed telomere
damage would exacerbate the Cdk1-mediated defect on
Cdc13. Cdc13 and Ku are both essential for telomere
integrity. The Ku complex is telomere associated and
helps to protect telomeres from degradation and from
inappropriate recombination (50,51). Deletion of Ku
causes telomere shortening. We measured the eﬀect of
T308A and S336A mutations on telomere length mainte-
nance in the Ku mutant background. Mutations of T308A
and S336A in the Ku mutant cells did not lead to further
shortening or senescence phenotype (Figure 5 and data
not shown). These results indicated that Cdk1-mediated
Cdc13 phosphorylation no longer plays a role in modulat-
ing telomere homeostasis in the absence of Ku.
We then asked if Cdk1-mediated Cdc13 phosphoryla-
tion plays a synergistic eﬀect with Tel1- or Mec1-mediated
regulation on telomere lengths. Mutations of CDC13 were
created in the tel1 and mec1 cells. Deletion of MEC1
leaded to mild telomere shortening, while deletion
of TEL1 caused severe telomere shortening. A further
reduction on telomere lengths was observed in mec1
cdc13-T308A and mec1 cdc13-T308S336A cells, but not
in tel1 cdc13-T308A and tel1 cdc13-T308S336A cells
(Figure 5). These results suggested that in the absence of
Figure 2. Cdc13 is directly phosphorylated by Cdk1 in vitro.( A) Schematic diagram of Cdc13 illustrates its domain structure and potential S/T
phosphorylation sites. The telomerase recruitment domain (RD) and DNA-binding domain (DBD) are indicated. (B) Cdk1-mediated phosphoryla-
tion of the telomerase recruitment domain of Cdc13 in vitro. Cdc28-HA and the kinase-dead Cdc28
K40L-HA were puriﬁed by immunoprecipitation
with an HA antibody. Immunoprecipitated kinases were analyzed by SDS–PAGE and western blotted with the HA antibody (shown at the bottom).
GST-Cdc13(1–252), GST-Cdc13(252–491), GST-Cdc13(601–781) and GST alone were puriﬁed. IP-kinase assay was performed as described (30) with
[g-
32P] ATP and phosphorylated proteins were detected by autoradiography (shown on top). The kinase reactions were also Coomassie stained
(shown below) to conﬁrm that lanes were equally loaded. (C) T308 is phosphorylated by Cdk1 in vitro. GST-Cdc13(252–491)-T308A, S336A and
S460A were subjected to the IP-kinase assay as described in (B). (D) S336 is phosphorylated by Cdk1 in vitro. GST-Cdc13(252–491)-T308A, GST-
Cdc13(252–491)-T308S336A and GST-Cdc13(252–491)-T308S460A were subjected to the IP-kinase assay as described in (B). (E) T308 is critical
for the Mec1-mediated T306 phosphorylation in vitro. The IP-kinase assay was performed as described in (B) with equal amount of GST-Cdc13
(276–332) wild-type, S306A and T308A using immunoprecipitated Cdc28-HA or Mec1-HA. Samples were collected at 10-min intervals for 60min.
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on other proteins), Cdk1-mediated phosphorylation
of Cdc13 has no measurable eﬀect on telomere length
homeostasis.
The stability of Cdc13-T308A is increased
Many studies have shown that CDK promotes protein
degradation, especially on cell cycle regulatory factors.
Rapid turnover of Cln2 at the S phase is achieved by
Cdk1-dependent phosphorylation (52). Proteolysis of
the anaphase-promoting complex early mitotic inhibitor,
Emi1, is induced by Cdk1 (53). In addition, TOP2-
inhibition leads to Cdk1-dependent degradation of an
ORC1/2 reservoir at mitosis (54). To examine whether
Cdk1-mediated phosphorylation of Cdc13 also modulates
the proteolysis of Cdc13, the relative Cdc13 stabilities in
wild-type and mutant strains were measured. Wild-type,
cdc13-T308A and cdc13-T308D strains were grown to log
phase, and cycloheximide was added to turn oﬀ the pro-
duction of Cdc13. The treatment was maintained for
90min, and the Cdc13 protein levels were evaluated.
As shown in Figure 6A, the half-life of Cdc13-T308A
was extensively expanded, comparing to that of wild-
type Cdc13. Furthermore, replacement of T308 with D
could revert this delay of degradation. Since Cdc13 is
phosphorylated by Cdk1 at late S/G2 phase, we also inves-
tigated the steady-state levels of Cdc13 after the action of
Cdk1. Increased level of Cdc13-T308A was observed in
G2/M-arrested cells (Figure 6B). These ﬁndings high-
lighted that, while Cdc13 protein is maintained in a cell
cycle-dependent manner, Cdk1-mediated phosphorylation
facilitates the degradation of Cdc13.
Cdk1-mediated phosphorylation of Cdc13 is not essential
for the de novo telomere addition
Lastly, we wish to address whether Cdk1-mediated Cdc13
phosphorylations are essential for de novo telomere addi-
tion. We tested the sudden telomere elongation by the de
novo telomere addition assay developed by Diede and
Gottschling (49). Strains were arrested at M phase by
nocodazole treatment, and then subjected to induction
of HO expression. Compared to wild-type cells, which
showed telomere elongations at the HO cut site, the
TG1–3/HO end was also elongated in T308A, S336A and
T308AS336A cells (Figure 7A). We next investigated
whether some partial defect in de novo telomere addition
could be detected in these mutants. After cells were
released into the cell cycle from a factor, both the control
Figure 3. Cdc13 is phosphorylated by Cdk1 in vivo.( A) Cdc13 is phosphorylated at the G2/M phase. CDC13 wild-type, T308A, S336A and
T308S336A strains were synchronized with a factor or nocodazole. Lysates were extracted and the phosphorylated Cdc13 was analyzed by western
blot analysis. Hypo- and hyper-phosphorylated Cdc13 are marked with single and double asterisks, respectively. (B) T308 and S336 were phos-
phorylated in vivo. Lysates of wild-type and Cdc13 mutants (T308A, S336A and T308S336A) were extracted from nocodazole synchronized cells.
Phosphorylated Cdc13 was separated in a SDS–PAGE containing 10mM of Phos-tag and analyzed by western blot analysis. (C) Cdc13 phosphor-
ylation at T308 and S336 were Tel1-independent. Lysates of wild-type and Cdc13 mutants (T308A, S336A, T308S336A) were extracted from
nocodazole synchronized TEL1 and tel1 strains. Phosphorylated Cdc13 was analyzed by western blot analysis. Pgk1 was served as a loading control.
(D) Phosphorylation of Cdc13 at T308 is Cdk1-dependent. Wild-type and cdc28-as1 strains were subjected to 1-NMPP1 treatment and GAL1-Sic1
N expressed cells were treated with dextrose (D) or galactose (G). Phosphorylation of Cdc13 was analyzed by western blot analysis.
Nucleic Acids Research, 2009,Vol.37, No. 11 3607Figure 4. Cdk1 and Tel1 phosphorylate Cdc13 at late S and G2 phases. (A) After a factor arrest and release, lysates from wild-type, cdc13-T308A
and tel1 cells were collected at 20-min intervals for 180min and Cdc13 was analyzed by western blot analysis. Data of FACS analysis are shown at
the bottom. Hypo- and hyper-phosphorylated Cdc13 are marked with single and double asterisks, respectively. (B) The FACS data of wild-type
and cdc13-T308A at 40min are shown. Percentages of cell cycle stages were quantiﬁed according to the manufactures instructions (Becton
Dickinson). (C) Lack of checkpoint activation in cdc13-T308A cells. Lysates of wild-type and cdc13-T308A cells were collected and Rad53
phosphorylation was analyzed by western blot analysis using a Rad53 antibody. Bleomycin treatment (5mU/ml, 3h) was used as a positive
control.
Figure 5. Telomere analysis of cdc13 mutants. Cdk1 phosphorylation sites of Cdc13 were mutated from T or S to A, D or E, and mutations were
created in wild-type, hdf1, mec1 and tel1 strains. DNA from each strain was digested with XhoI, separated in a 1% agarose gel, transferred to a
nylon membrane and hybridized with a Y0 probe. Cells used in this experiment had pop-out the YIP cdc13 URA3 plasmid for at least 50
generations.
3608 Nucleic Acids Research, 2009, Vol. 37,No. 11and the experimental strains proceeded with indistinguish-
able kinetics of telomere addition through the subsequent
cell cycle (Figure 7B). These results indicated that phos-
phorylation of Cdc13 at amino acids 308 and 336 are
not essential for de novo telomere addition.
DISCUSSION
Cdc13 recruits telomerase to its site of action through an
electrostatic interaction with a telomerase component Est1
(22,23,55). We previously showed that Tel1 and Mec1
phosphorylate Cdc13 and govern the telomerase recruit-
ment function of Cdc13 (30). Consistent with the recent
ﬁnding that Cdk1 regulates Cdc13 (29), in this article we
additionally demonstrated that Cdk1 phosphorylates
Cdc13 at the telomerase recruitment domain. While it
currently lacks structural information between Cdc13
and Est1 in the recruitment interface, we speculate that
the hypernegatively charged domain of Cdc13 contributed
by Tel1, Mec1 and Cdk1 may provide an optimal interface
to recruit the potential positively charged domain near the
amino acid 444 lysine residue of Est1 (56). This hyperne-
gatively charged domain of Cdc13 forms at the late S
and lasts to G2 phase, right at the timing for telomerase
to function on telomeres.
Figure 7. De novo telomere addition in cdc13 mutants. (A) cdc13 mutants were introduced into UCC5706. Strains were arrested by nocodazole.
Galactose was added to arrested culture to induce the expression of HO endonuclease. DNA was isolated after 0, 1, 2, 3 and 4h and digested with
SpeI. Southern blot analysis was performed with a probe that recognizes sequence distal to the HO recognition site. De novo telomere addition is
marked with an asterisk. (B) Strains were arrested in G1 by a factor, galactose was added to induce HO expression for 2h, and cells were
resuspended in prewarmed YEPD to release. Samples were taken at diﬀerent time points for 24h for analysis as described in (A).
Figure 6. Cdk1-mediated phosphorylation regulates the stability of
Cdc13. Western blot analysis of the stability of Cdc13 was performed.
(A) Wild-type, cdc13-T308A and cdc13-T308D strains were treated with
cycloheximide. After cycloheximide treatment, cells were collected at
30-min intervals for 90min. Lysates were TCA-precipitated, subjected
to a 10% SDS–PAGE and transferred for western blot analysis using
a Myc antibody. Pgk1 was served as a loading control. (B) Strains
were arrested by nocodazole. Western blot analysis was performed as
described in (A). The percentages of the expression levels of Cdc13
compared to that of the wild-type are shown below.
Nucleic Acids Research, 2009,Vol.37, No. 11 3609An intriguing ﬁnding of this study is that Cdk1-
mediated phosphorylation is required for, in addition to
optimal telomerase recruitment, the proper turnover of
Cdc13. While the protein level of Cdc13 is well regulated
throughout the cell cycle, which peaks at late S/G2 phase
and drops at the G1 phase, we found that phosphorylation
at T308 is critical for the rapid degradation of Cdc13.
What kind of disturbances would be caused by under-
degraded Cdc13 existing in the nucleus after the G2
phase of the cell cycle is still unclear. Further identiﬁcation
of the proteolysis pathway of Cdc13 will be important to
study this eﬀect by uncoupling the function of tuning the
protein level of Cdc13 from the function of telomerase
recruitment of Cdc13 contributed by Cdk1.
Phosphoproteomics has been used to proﬁle thousands
of phosphorylation in cells. Using mass spectrometry to
analyze phosphorylation sites in wild-type S. cerevisiae,
both S306 and T308 of Cdc13 were found to be phos-
phorylated in vivo (57). In our previous study, mutations
at the Tel1/Mec1 phosphorylation sites did not lead to an
alteration of protein levels of Cdc13 (30). Interestingly, the
T308 residue is very close to a Mec1-regulated site, S306,
and T308 is critical for the full activity of Mec1 on S306,
at least in our in vitro assay (Figure 2E). These results
indicate that a conformational change at T308 might mod-
ulate Mec1-mediated Cdc13 phosphorylation. However,
the Cdk1-mediated telomere shortening observed in the
T308 strain was abolished in the absence of Tel1.
Altogether these data suggest that Tel1 makes a greater
impact, while Mec1 and Cdk1 kinases play supporting
roles, to optimize the reaction of telomerase recruitment.
Previous studies showed that Cdk1 mutation could
produce long single strand G-tails at telomeres (26,28),
which was not observed in our T308S336A cells (data
not shown). It remains possible, in addition to Cdc13,
Cdk1 may target other proteins during telomere replica-
tion. In that case, the telomeric eﬀect of Cdk1 on Cdc13
(26,28) should be masked in the cdc28-4 cells, that is, the
cdc28-4 mutation causes a greater telomeric alteration
than cdc13-T308A. Further studies to illustrate other tar-
gets of Cdk1 in telomere replication will be required in
order to address this possibility.
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